Agios Pharmaceuticals | 流动负债



Current Liabilities 更改 日
AbbVie USD 38.75B 4.31B 2024-12
Agios Pharmaceuticals USD 81.16M 38.3M 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Amgen USD 23.1B 2.79B 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Astellas Pharma JPY 1.06T 90.95B 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.53B 103.8M 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Daiichi Sankyo JPY 754.03B 41.68B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 403.77M 9.42M 2025-01
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Incyte USD 1.89B 244.96M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Merck USD 28.42B 1.17B 2024-12
Moderna USD 1.6B 602M 2025-03
Novartis USD 28.69B 560M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Agios Pharmaceuticals 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.